June 2020: Burstein, Mayrose and Tuller in a new Genome Editing Consortium

The Israel Innovation Authority has announced the establishment of the CRISPR-IL consortium. The TAU team consists of three Edmond J. Safra members, Dr. Dudu Burstein, Prof. Itay Mayrose (Life Sciences) and Prof. Tamir Tuller (Engineering).

June 2020: Burstein, Mayrose and Tuller in a new Genome Editing Consortium

The Israel Innovation Authority has announced the establishment of the CRISPR-IL consortium. The TAU team consists of three Edmond J. Safra members, Dr. Dudu Burstein, Prof. Itay Mayrose (Life Sciences) and Prof. Tamir Tuller (Engineering). 

 

The CRISPR-IL consortium will focus on the integration of artificial intelligence and CRISPR technologies to develop advanced computational tools for genome editing. It includes companies from a variety of fields, which will partner with leading scientists from academia and hospitals. It has a budget of $10.36 million for a period of 18 months.

 

CRISPR is a genome-editing technology for detecting and modifying DNA sequences. Among its potential uses are the development of advanced and personalized medical treatments, modification of genes that contribute to diseases, and improving the quality of agricultural produce.

 

The new consortium was featured in the online newspapers Jerusalem Post, Calcalist, and Hayadan.

 

 

Tel Aviv University, P.O. Box 39040, Tel Aviv 6997801, Israel
UI/UX Basch_Interactive